A randomized, open label, single dose, crossover, bioequivalence study of Mebeverin 135mg tablet of Amin Pharm. Co., IRAN in comparison of Duspatalin 135mg tablet of Abbott in 24 healthy adult subjects under fasting condition
To Compare the Efficacy of (Rifaximin + Mebeverine), (Rifaximin + Amitriptyline), and (Rifaximin + Psyllium Husk) in Irritable Bowel Syndrome Associated With Diarrhea
The goal of this clinical trial is to compare the efficacy of four different drugs in combination for management of irritable bowel syndrome (IBS)-associated diarrhea. The main question to answer is: Is there a significant difference in effect of different drug combinations in management of irritable bowel syndrome with diarrhea? Participants will be divided into 3 treatment groups. Each group will be given a combination of drugs for 2 weeks At the end of study, efficacy of different drug combinations and their potential side effects will be compared between the treatment groups
3D‐QSAR pharmacophore modeling, virtual screening, molecular docking, MD simulations, in vitro and in vivo studies to identify potential anti‐hyperplasia drugs
Article
作者: Akbar, Muhammad Yasir ; Khan, Dildar ; Wang, Hao ; Haq, Ihsan-Ul ; Chen, Jian-Zhong ; Khan, Muhammad Zafar Irshad
2024-01-01·Sudebno-meditsinskaia ekspertiza
Development of selective method for identifying mebeverine in hair
Article
作者: Balabanova, O L ; Vikman, P S ; Strelova, O Yu ; Grebenyuk, A N
2024-01-01·Sudebno-meditsinskaia ekspertiza
Development of selective method for mebeverine detection in blood
Article
作者: Balabanova, O L ; Vikman, P S ; Strelova, O Yu ; Grebenyuk, A N